Resaro builds testing and evaluation tools for AI systems in high-stakes domains like healthcare and autonomous systems. The tech stack (Python, PyTorch, RLHF, BERT, Node.js/React) reflects a dual emphasis on ML model evaluation and web-based tooling. Active projects span radiology AI evaluation, RL system stress-testing, and synthetic data generation — indicating the company is solving concrete assurance problems in regulated verticals rather than offering generic AI testing. The senior-heavy hiring profile (6 senior vs. 2 mid-level) and focus on healthcare standards and red-teaming suggest early-stage positioning toward enterprise compliance buyers.
Resaro is an independent AI assurance provider founded in 2023 with co-headquarters in Singapore and Europe. The company specializes in testing and safety evaluation for dual-use AI systems, with particular focus on mission-critical applications in healthcare and autonomous systems. Their platform combines automated testing frameworks, stress-testing capabilities for reinforcement learning, and evaluation pipelines aligned with global regulatory standards. The team (11–50 employees) is distributed across Singapore and Germany, with active hiring concentrated in engineering and data roles.
Resaro builds tools to evaluate performance, safety, and security of AI systems. Their platform includes stress-testing frameworks for RL systems, evaluation pipelines for medical AI (especially radiology), synthetic data generation, and uncertainty-aware testing tools aligned with healthcare regulatory standards.
Backend and ML: Python, PyTorch, NumPy, RLHF, BERT, GPT. Frontend: Node.js, React, JavaScript/TypeScript. Operations: Jira, Confluence, Google Workspace, Xero, Nextcloud.
Other companies in the same industry, closest in size